Eyelid myxoma in carney complex without PRKAR1A allelic loss

American Journal of Medical Genetics

Volumn 130 A, Issue 4, 2004, Pages 395-397

  Tsilou, Ekaterini T ^a,b   Chan, Chi Chao ^b   Sandrini, Fabiano ^c   Rubin, Benjamin I ^a   De, Fen Shen ^b   Carney, J Aidan ^d   Kaiser Kupfer, Muriel ^a   Stratakis, Constantine A ^c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d MAYO CLINIC   (United States)

Author keywords

Loss of heterozygosity; Multiple endocrine neoplasia

Indexed keywords

ALLELE; ARTICLE; CARCINOGENESIS; CARNEY COMPLEX; CASE REPORT; EYE INJURY; GENE MUTATION; HETEROZYGOSITY; HUMAN; IMMUNOHISTOCHEMISTRY; MYXOMA; PRIORITY JOURNAL;

ABNORMALITIES, MULTIPLE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENDOCRINE SYSTEM DISEASES; EYELID NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY; MYXOMA; PIGMENTATION DISORDERS; PROTEINS;

EID: 7444257863     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.a.30279     Document Type: Article

References (15)

1. Bardeesy N, Sinha M, Hezel AT, Signoretti S, Hathaway NA, Sharpless NE, Loda M, Carrasco DR, DePinho RA. 2002. Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature 419:162-167.
2. Bertherat J, Sandrini F, Matyakhina L, Bei T, Stergiopoulos S, Papageorgiou T, Bourdeau I, Kirschner LS, Vincent-Dejean C, Perlemoine K, Gisquel C, Bertagna X, Stratakis CA. 2003. Molecular and functional analysis of PRKARIA and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression. Cancer Res 63:5308-5319.
3. Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL. 1985. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine 64:270-283.
4. Groussin L, Jullian E, Perlemoine K, Leheup B, Luton JP, Bertagna X, Bertherat J. 2002. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease (PPNAD). J Clin Endocrinol Metab 87:4324-4329.
5. Jones PA. 2003. Epigenetics in carcinogenesis and cancer prevention. Ann NY Acad Sci 983:213-219.
6. Kirschner LS, Sandrini F, Monbo J, Lin JP, Carney JA, Stratakis CA. 2000a. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex. Hum Mol Genet 9:3037-3046.
7. Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, ChoChung YS, Stratakis CA. 2000b. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 26:89-92.
8. Robinson-White A, Hundley TR, Shiferaw M, Bertherat J, Sandrini F, Stratakis CA. 2003. Protein kinase-A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1/2. Hum Mol Genet 12:1475-1484.
9. Sandrini F, Matyakhina L, Sarlis NJ, Farmakidis C, Kirschner LS, Gimm O, Stratakis CA. 2002a. Regulatory subunit type I- of protein kinase A (PKKAR1A): A tumor-suppressor gene for sporadic thyroid cancer. Genes Chromosomes Cancer 35:182-192.
10. Sandrini F, Kirschner LS, Bei T, Farmakidis C, Yasufuku-Takano J, Takano K, Prezant TR, Marx SJ, Farrell WE, Clayton RN, Groussin L, Bertherat J, Stratakis CA. 2002b. PRKAR1A, one of the Carney complex genes, and its locus (17q22-24) are rarely altered in pituitary tumours outside the Carney complex. J Med Genet 39:78.
11. Stergiopoulos S, Stratakis CA. 2003. Human tumors associated with Carney complex and germline PRKAR1A mutations: A protein kinase A disease! FEBS 546:59-64.
12. Stratakis CA. 2002. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit (PRKAR1A) in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas" (Carney complex). Ann NY Acad Sci 968:3-21.
13. Stratakis CA. 2003. Genetics of adrenocortical tumors: Gatekeepers, landscapers and conductors in symphony. Trends Endocrinol Metabol 14:404-410.
14. van der Weyden L, Jonkers J, Bradley A. 2002. Cancer: Stuck at first base. Nature 419:127-128.
15. Zhou XP, Gimm O, Hampel H, Niemann T, Walker MJ, Eng C. 2000. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation. Am J Pathol 157:1123-1128.